Non-invasive Measurement of Blood Glucose, Blood Pressure and Extrapolation of QRS Complex Using a Wrist Wearable Photoplethysmography Sensor
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Diabetes
- Sponsor
- Mayo Clinic
- Enrollment
- 87
- Locations
- 1
- Primary Endpoint
- Systolic Blood Pressure
- Status
- Terminated
- Last Updated
- 6 months ago
Overview
Brief Summary
The purpose of this research is to compare blood glucose, blood pressure and electrocardiogram (ECG) readings on the LIFELEAF Smartwatch compared to standard methods of measurement.
Investigators
Narayan (Guru) G. Kowlgi
Principal Investigator
Mayo Clinic
Eligibility Criteria
Inclusion Criteria
- •Diabetic patients on insulin undergoing four times daily blood sugar checks as part of standard of care.
- •Patients undergoing continuous monitoring for heart rate, ECG and blood pressure as part of their routine care.
- •Patients undergoing invasive and noninvasive electrophysiologic procedures.
Exclusion Criteria
- •Patients unable to provide informed consent.
- •Patients without arms as these are needed to wear the wrist-based sensor.
Outcomes
Primary Outcomes
Systolic Blood Pressure
Time Frame: Baseline
Difference in measurement of Systolic Blood Pressure using the wrist-based PPG sensor versus invasive measurement of blood pressure measured in millimeters of mercury (mmHg).
Diastolic Blood Pressure
Time Frame: Baseline
Difference in measurement of Diastolic Blood Pressure using the wrist-based PPG sensor versus invasive measurement of blood pressure measured in millimeters of mercury (mmHg).
Blood Glucose Level
Time Frame: Baseline
The difference in measurement of blood glucose levels using the wrist-based PPG sensor versus standard blood-based measurement measured in milligrams per deciliter (mg/dL) in subjects who had standard of care blood glucose monitoring done. Only subjects who are hospitalized and diabetic per standard of care receive standard of care blood-based glucose monitoring.